603229 logo

Zhejiang Ausun Pharmaceutical Co., Ltd. Stock Price

SHSE:603229 Community·CN¥7.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

603229 Share Price Performance

CN¥0
-8.67 (-100.00%)
CN¥0
-8.67 (-100.00%)
Price CN¥0

603229 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

1 Risk
2 Rewards

Zhejiang Ausun Pharmaceutical Co., Ltd. Key Details

CN¥751.1m

Revenue

CN¥361.4m

Cost of Revenue

CN¥389.8m

Gross Profit

CN¥204.9m

Other Expenses

CN¥184.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 29, 2026
0.22
51.89%
24.61%
16.0%
View Full Analysis

About 603229

Founded
2010
Employees
1219
CEO
Zhiguo Zheng
WebsiteView website
www.ausunpharm.com

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.

Recent 603229 News & Updates

Recent updates

No updates